Montrusco Bolton Investments Inc. Abb Vie Inc. Transaction History

Montrusco Bolton Investments Inc.

$8.05 Billion
Q4 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$137.62 - $174.96 $758,561 - $964,379	-5,512 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$131.98 - $163.75 $849,159 - $1.05 Million	-6,434 Reduced 53.86%	5,512 $894,000
Q4 2021 Feb 07, 2022	BUY	$107.43 - $135.93 $191,332 - $242,091	1,781 Added 17.52%	11,946 $1.62 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $527,318 - $598,585	4,956 Added 95.14%	10,165 $1.1 Million
Q2 2021 Aug 17, 2021	SELL	$105.21 - $117.21 $1.8 Million - $2 Million	-17,098 Reduced 76.65%	5,209 $587,000
Q1 2021 May 12, 2021	BUY	$102.3 - $112.62 $242,348 - $266,796	2,369 Added 11.88%	22,307 $2.41 Million
Q4 2020 Feb 16, 2021	SELL	$80.49 - $108.67 $1.23 Million - $1.66 Million	-15,263 Reduced 43.36%	19,938 $2.14 Million
Q3 2020 Nov 09, 2020	BUY	$85.91 - $100.83 $715,372 - $839,611	8,327 Added 30.99%	35,201 $3.08 Million
Q2 2020 Aug 12, 2020	BUY	$73.37 - $98.18 $1.6 Million - $2.14 Million	21,831 Added 432.9%	26,874 $2.55 Million
Q1 2020 May 14, 2020	BUY	$64.5 - $97.79 $10,900 - $16,526	169 Added 3.47%	5,043 $384,000
Q3 2019 Nov 08, 2019	BUY	$62.98 - $75.72 $13,792 - $16,582	219 Added 4.7%	4,874 $388,000
Q2 2019 Aug 05, 2019	SELL	$65.7 - $83.98 $1.37 Million - $1.75 Million	-20,827 Reduced 81.73%	4,655 $339,000
Q1 2019 May 10, 2019	BUY	$77.14 - $90.79 $1.52 Million - $1.79 Million	19,766 Added 345.8%	25,482 $2.02 Million
Q4 2018 Feb 12, 2019	SELL	$77.85 - $96.01 $314,436 - $387,784	-4,039 Reduced 41.4%	5,716 $527,000
Q3 2018 Oct 10, 2018	SELL	$88.91 - $98.84 $80,107 - $89,054	-901 Reduced 8.46%	9,755 $923,000
Q2 2018 Jul 11, 2018	SELL	$89.78 - $106.23 $128,924 - $152,546	-1,436 Reduced 11.88%	10,656 $987,000
Q1 2018 Apr 05, 2018	SELL	$92.01 - $123.21 $956,351 - $1.28 Million	-10,394 Reduced 46.22%	12,092 $1.15 Million
Q4 2017 Jan 12, 2018	BUY	$89.56 - $98.21 $1.68 Million - $1.84 Million	18,745 Added 501.07%	22,486 $2.18 Million
Q3 2017 Oct 18, 2017	SELL	$69.85 - $89.22 $770,445 - $984,096	-11,030 Reduced 74.67%	3,741 $332,000
Q2 2017 Aug 14, 2017	BUY	N/A	14,771	14,771 $1.07 Million

Others Institutions Holding ABBV

# of Institutions

3,891

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $325B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Montrusco Bolton Investments Inc., based on Form 13F filings with the SEC.

News

Stay updated on Montrusco Bolton Investments Inc. with notifications on news.

Account